世界のグリコシル化バイオシミラー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glycosylated Biosimilars Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2597 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、グリコシル化バイオシミラーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（mAb、EPO）、用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・グリコシル化バイオシミラーの市場動向 ・企業の競争状況、市場シェア ・グリコシル化バイオシミラーの種類別市場規模（mAb、EPO） ・グリコシル化バイオシミラーの用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他） ・グリコシル化バイオシミラーの北米市場規模2016-2027（アメリカ、カナダ） ・グリコシル化バイオシミラーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・グリコシル化バイオシミラーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・グリコシル化バイオシミラーの中南米市場規模2016-2027（メキシコ、ブラジル） ・グリコシル化バイオシミラーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sandoz、Pfizer、Teva Pahrmaceutical、Celltrion、Biocon、Amgen、Samsung Biologics、Mylan、Dr. Reddy's Laboratories、Stada Arzneimittel AG） ・結論

Glycosylated Biosimilars include mA, EPO etc in this report.

Market Analysis and Insights: Global Glycosylated Biosimilars Market
The global Glycosylated Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glycosylated Biosimilars market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glycosylated Biosimilars market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glycosylated Biosimilars market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glycosylated Biosimilars market.

Global Glycosylated Biosimilars Scope and Market Size
Glycosylated Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glycosylated Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
mAb
EPO

Segment by Application
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy’s Laboratories

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycosylated Biosimilars Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 mAb
1.2.3 EPO
1.3 Market by Application
1.3.1 Global Glycosylated Biosimilars Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glycosylated Biosimilars Market Perspective (2016-2027)
2.2 Glycosylated Biosimilars Growth Trends by Regions
2.2.1 Glycosylated Biosimilars Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glycosylated Biosimilars Historic Market Share by Regions (2016-2021)
2.2.3 Glycosylated Biosimilars Forecasted Market Size by Regions (2022-2027)
2.3 Glycosylated Biosimilars Industry Dynamic
2.3.1 Glycosylated Biosimilars Market Trends
2.3.2 Glycosylated Biosimilars Market Drivers
2.3.3 Glycosylated Biosimilars Market Challenges
2.3.4 Glycosylated Biosimilars Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glycosylated Biosimilars Players by Revenue
3.1.1 Global Top Glycosylated Biosimilars Players by Revenue (2016-2021)
3.1.2 Global Glycosylated Biosimilars Revenue Market Share by Players (2016-2021)
3.2 Global Glycosylated Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glycosylated Biosimilars Revenue
3.4 Global Glycosylated Biosimilars Market Concentration Ratio
3.4.1 Global Glycosylated Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycosylated Biosimilars Revenue in 2020
3.5 Glycosylated Biosimilars Key Players Head office and Area Served
3.6 Key Players Glycosylated Biosimilars Product Solution and Service
3.7 Date of Enter into Glycosylated Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glycosylated Biosimilars Breakdown Data by Type
4.1 Global Glycosylated Biosimilars Historic Market Size by Type (2016-2021)
4.2 Global Glycosylated Biosimilars Forecasted Market Size by Type (2022-2027)

5 Glycosylated Biosimilars Breakdown Data by Application
5.1 Global Glycosylated Biosimilars Historic Market Size by Application (2016-2021)
5.2 Global Glycosylated Biosimilars Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glycosylated Biosimilars Market Size (2016-2027)
6.2 North America Glycosylated Biosimilars Market Size by Type
6.2.1 North America Glycosylated Biosimilars Market Size by Type (2016-2021)
6.2.2 North America Glycosylated Biosimilars Market Size by Type (2022-2027)
6.2.3 North America Glycosylated Biosimilars Market Size by Type (2016-2027)
6.3 North America Glycosylated Biosimilars Market Size by Application
6.3.1 North America Glycosylated Biosimilars Market Size by Application (2016-2021)
6.3.2 North America Glycosylated Biosimilars Market Size by Application (2022-2027)
6.3.3 North America Glycosylated Biosimilars Market Size by Application (2016-2027)
6.4 North America Glycosylated Biosimilars Market Size by Country
6.4.1 North America Glycosylated Biosimilars Market Size by Country (2016-2021)
6.4.2 North America Glycosylated Biosimilars Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Glycosylated Biosimilars Market Size (2016-2027)
7.2 Europe Glycosylated Biosimilars Market Size by Type
7.2.1 Europe Glycosylated Biosimilars Market Size by Type (2016-2021)
7.2.2 Europe Glycosylated Biosimilars Market Size by Type (2022-2027)
7.2.3 Europe Glycosylated Biosimilars Market Size by Type (2016-2027)
7.3 Europe Glycosylated Biosimilars Market Size by Application
7.3.1 Europe Glycosylated Biosimilars Market Size by Application (2016-2021)
7.3.2 Europe Glycosylated Biosimilars Market Size by Application (2022-2027)
7.3.3 Europe Glycosylated Biosimilars Market Size by Application (2016-2027)
7.4 Europe Glycosylated Biosimilars Market Size by Country
7.4.1 Europe Glycosylated Biosimilars Market Size by Country (2016-2021)
7.4.2 Europe Glycosylated Biosimilars Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glycosylated Biosimilars Market Size (2016-2027)
8.2 Asia-Pacific Glycosylated Biosimilars Market Size by Type
8.2.1 Asia-Pacific Glycosylated Biosimilars Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glycosylated Biosimilars Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glycosylated Biosimilars Market Size by Type (2016-2027)
8.3 Asia-Pacific Glycosylated Biosimilars Market Size by Application
8.3.1 Asia-Pacific Glycosylated Biosimilars Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glycosylated Biosimilars Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glycosylated Biosimilars Market Size by Application (2016-2027)
8.4 Asia-Pacific Glycosylated Biosimilars Market Size by Region
8.4.1 Asia-Pacific Glycosylated Biosimilars Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glycosylated Biosimilars Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glycosylated Biosimilars Market Size (2016-2027)
9.2 Latin America Glycosylated Biosimilars Market Size by Type
9.2.1 Latin America Glycosylated Biosimilars Market Size by Type (2016-2021)
9.2.2 Latin America Glycosylated Biosimilars Market Size by Type (2022-2027)
9.2.3 Latin America Glycosylated Biosimilars Market Size by Type (2016-2027)
9.3 Latin America Glycosylated Biosimilars Market Size by Application
9.3.1 Latin America Glycosylated Biosimilars Market Size by Application (2016-2021)
9.3.2 Latin America Glycosylated Biosimilars Market Size by Application (2022-2027)
9.3.3 Latin America Glycosylated Biosimilars Market Size by Application (2016-2027)
9.4 Latin America Glycosylated Biosimilars Market Size by Country
9.4.1 Latin America Glycosylated Biosimilars Market Size by Country (2016-2021)
9.4.2 Latin America Glycosylated Biosimilars Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glycosylated Biosimilars Market Size (2016-2027)
10.2 Middle East & Africa Glycosylated Biosimilars Market Size by Type
10.2.1 Middle East & Africa Glycosylated Biosimilars Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glycosylated Biosimilars Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glycosylated Biosimilars Market Size by Type (2016-2027)
10.3 Middle East & Africa Glycosylated Biosimilars Market Size by Application
10.3.1 Middle East & Africa Glycosylated Biosimilars Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glycosylated Biosimilars Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glycosylated Biosimilars Market Size by Application (2016-2027)
10.4 Middle East & Africa Glycosylated Biosimilars Market Size by Country
10.4.1 Middle East & Africa Glycosylated Biosimilars Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glycosylated Biosimilars Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sandoz
11.1.1 Sandoz Company Details
11.1.2 Sandoz Business Overview
11.1.3 Sandoz Glycosylated Biosimilars Introduction
11.1.4 Sandoz Revenue in Glycosylated Biosimilars Business (2016-2021)
11.1.5 Sandoz Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Glycosylated Biosimilars Introduction
11.2.4 Pfizer Revenue in Glycosylated Biosimilars Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Teva Pahrmaceutical
11.3.1 Teva Pahrmaceutical Company Details
11.3.2 Teva Pahrmaceutical Business Overview
11.3.3 Teva Pahrmaceutical Glycosylated Biosimilars Introduction
11.3.4 Teva Pahrmaceutical Revenue in Glycosylated Biosimilars Business (2016-2021)
11.3.5 Teva Pahrmaceutical Recent Development
11.4 Celltrion
11.4.1 Celltrion Company Details
11.4.2 Celltrion Business Overview
11.4.3 Celltrion Glycosylated Biosimilars Introduction
11.4.4 Celltrion Revenue in Glycosylated Biosimilars Business (2016-2021)
11.4.5 Celltrion Recent Development
11.5 Biocon
11.5.1 Biocon Company Details
11.5.2 Biocon Business Overview
11.5.3 Biocon Glycosylated Biosimilars Introduction
11.5.4 Biocon Revenue in Glycosylated Biosimilars Business (2016-2021)
11.5.5 Biocon Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Glycosylated Biosimilars Introduction
11.6.4 Amgen Revenue in Glycosylated Biosimilars Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Details
11.7.2 Samsung Biologics Business Overview
11.7.3 Samsung Biologics Glycosylated Biosimilars Introduction
11.7.4 Samsung Biologics Revenue in Glycosylated Biosimilars Business (2016-2021)
11.7.5 Samsung Biologics Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Glycosylated Biosimilars Introduction
11.8.4 Mylan Revenue in Glycosylated Biosimilars Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Dr. Reddy’s Laboratories
11.9.1 Dr. Reddy’s Laboratories Company Details
11.9.2 Dr. Reddy’s Laboratories Business Overview
11.9.3 Dr. Reddy’s Laboratories Glycosylated Biosimilars Introduction
11.9.4 Dr. Reddy’s Laboratories Revenue in Glycosylated Biosimilars Business (2016-2021)
11.9.5 Dr. Reddy’s Laboratories Recent Development
11.10 Stada Arzneimittel AG
11.10.1 Stada Arzneimittel AG Company Details
11.10.2 Stada Arzneimittel AG Business Overview
11.10.3 Stada Arzneimittel AG Glycosylated Biosimilars Introduction
11.10.4 Stada Arzneimittel AG Revenue in Glycosylated Biosimilars Business (2016-2021)
11.10.5 Stada Arzneimittel AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glycosylated Biosimilars Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of mAb
Table 3. Key Players of EPO
Table 4. Global Glycosylated Biosimilars Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Glycosylated Biosimilars Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Glycosylated Biosimilars Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Glycosylated Biosimilars Market Share by Regions (2016-2021)
Table 8. Global Glycosylated Biosimilars Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Glycosylated Biosimilars Market Share by Regions (2022-2027)
Table 10. Glycosylated Biosimilars Market Trends
Table 11. Glycosylated Biosimilars Market Drivers
Table 12. Glycosylated Biosimilars Market Challenges
Table 13. Glycosylated Biosimilars Market Restraints
Table 14. Global Glycosylated Biosimilars Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Glycosylated Biosimilars Market Share by Players (2016-2021)
Table 16. Global Top Glycosylated Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycosylated Biosimilars as of 2020)
Table 17. Ranking of Global Top Glycosylated Biosimilars Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Glycosylated Biosimilars Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Glycosylated Biosimilars Product Solution and Service
Table 21. Date of Enter into Glycosylated Biosimilars Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Glycosylated Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Glycosylated Biosimilars Revenue Market Share by Type (2016-2021)
Table 25. Global Glycosylated Biosimilars Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Glycosylated Biosimilars Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Glycosylated Biosimilars Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Glycosylated Biosimilars Revenue Market Share by Application (2016-2021)
Table 29. Global Glycosylated Biosimilars Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Glycosylated Biosimilars Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Glycosylated Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Glycosylated Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Glycosylated Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Glycosylated Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Glycosylated Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Glycosylated Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Glycosylated Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Glycosylated Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Glycosylated Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Glycosylated Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Glycosylated Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Glycosylated Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Glycosylated Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Glycosylated Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Glycosylated Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Glycosylated Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Glycosylated Biosimilars Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Glycosylated Biosimilars Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Glycosylated Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Glycosylated Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Glycosylated Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Glycosylated Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Glycosylated Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Glycosylated Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Glycosylated Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Glycosylated Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Glycosylated Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Glycosylated Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Glycosylated Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Glycosylated Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sandoz Company Details
Table 62. Sandoz Business Overview
Table 63. Sandoz Glycosylated Biosimilars Product
Table 64. Sandoz Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 65. Sandoz Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Glycosylated Biosimilars Product
Table 69. Pfizer Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Teva Pahrmaceutical Company Details
Table 72. Teva Pahrmaceutical Business Overview
Table 73. Teva Pahrmaceutical Glycosylated Biosimilars Product
Table 74. Teva Pahrmaceutical Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 75. Teva Pahrmaceutical Recent Development
Table 76. Celltrion Company Details
Table 77. Celltrion Business Overview
Table 78. Celltrion Glycosylated Biosimilars Product
Table 79. Celltrion Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 80. Celltrion Recent Development
Table 81. Biocon Company Details
Table 82. Biocon Business Overview
Table 83. Biocon Glycosylated Biosimilars Product
Table 84. Biocon Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 85. Biocon Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Glycosylated Biosimilars Product
Table 89. Amgen Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Samsung Biologics Company Details
Table 92. Samsung Biologics Business Overview
Table 93. Samsung Biologics Glycosylated Biosimilars Product
Table 94. Samsung Biologics Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 95. Samsung Biologics Recent Development
Table 96. Mylan Company Details
Table 97. Mylan Business Overview
Table 98. Mylan Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 99. Mylan Recent Development
Table 100. Dr. Reddy's Laboratories Company Details
Table 101. Dr. Reddy's Laboratories Business Overview
Table 102. Dr. Reddy's Laboratories Glycosylated Biosimilars Product
Table 103. Dr. Reddy's Laboratories Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 104. Dr. Reddy's Laboratories Recent Development
Table 105. Stada Arzneimittel AG Company Details
Table 106. Stada Arzneimittel AG Business Overview
Table 107. Stada Arzneimittel AG Glycosylated Biosimilars Product
Table 108. Stada Arzneimittel AG Revenue in Glycosylated Biosimilars Business (2016-2021) & (US$ Million)
Table 109. Stada Arzneimittel AG Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glycosylated Biosimilars Market Share by Type: 2020 VS 2027
Figure 2. mAb Features
Figure 3. EPO Features
Figure 4. Global Glycosylated Biosimilars Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Chronic Diseases Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Blood Disorders Case Studies
Figure 9. Growth Hormone Deficiency Case Studies
Figure 10. Infectious Diseases Case Studies
Figure 11. Other Diseases Case Studies
Figure 12. Glycosylated Biosimilars Report Years Considered
Figure 13. Global Glycosylated Biosimilars Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Glycosylated Biosimilars Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Glycosylated Biosimilars Market Share by Regions: 2020 VS 2027
Figure 16. Global Glycosylated Biosimilars Market Share by Regions (2022-2027)
Figure 17. Global Glycosylated Biosimilars Market Share by Players in 2020
Figure 18. Global Top Glycosylated Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycosylated Biosimilars as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Glycosylated Biosimilars Revenue in 2020
Figure 20. Global Glycosylated Biosimilars Revenue Market Share by Type (2016-2021)
Figure 21. Global Glycosylated Biosimilars Revenue Market Share by Type (2022-2027)
Figure 22. North America Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Glycosylated Biosimilars Market Share by Type (2016-2027)
Figure 24. North America Glycosylated Biosimilars Market Share by Application (2016-2027)
Figure 25. North America Glycosylated Biosimilars Market Share by Country (2016-2027)
Figure 26. United States Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Glycosylated Biosimilars Market Share by Type (2016-2027)
Figure 30. Europe Glycosylated Biosimilars Market Share by Application (2016-2027)
Figure 31. Europe Glycosylated Biosimilars Market Share by Country (2016-2027)
Figure 32. Germany Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Glycosylated Biosimilars Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Glycosylated Biosimilars Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Glycosylated Biosimilars Market Share by Region (2016-2027)
Figure 42. China Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Glycosylated Biosimilars Market Share by Type (2016-2027)
Figure 50. Latin America Glycosylated Biosimilars Market Share by Application (2016-2027)
Figure 51. Latin America Glycosylated Biosimilars Market Share by Country (2016-2027)
Figure 52. Mexico Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Glycosylated Biosimilars Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Glycosylated Biosimilars Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Glycosylated Biosimilars Market Share by Country (2016-2027)
Figure 58. Turkey Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Glycosylated Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Sandoz Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 63. Teva Pahrmaceutical Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 64. Celltrion Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 65. Biocon Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 67. Samsung Biologics Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 69. Dr. Reddy's Laboratories Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 70. Stada Arzneimittel AG Revenue Growth Rate in Glycosylated Biosimilars Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---